Fusion Antibodies (LSE:FAB) Long-Term Debt : £0.00 Mil (As of Sep. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Fusion Antibodies Long-Term Debt?

Fusion Antibodies's Long-Term Debt for the quarter that ended in Sep. 2024 was £0.00 Mil.

Fusion Antibodies's quarterly Long-Term Debt declined from Sep. 2023 (£0.03 Mil) to Mar. 2024 (£0.00 Mil) but then stayed the same from Mar. 2024 (£0.00 Mil) to Sep. 2024 (£0.00 Mil).

Fusion Antibodies Long-Term Debt Historical Data

The historical data trend for Fusion Antibodies's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fusion Antibodies Long-Term Debt Chart

Fusion Antibodies Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Long-Term Debt

Get a 7-Day Free Trial

Fusion Antibodies Semi-Annual Data
	Mar15	Mar16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Long-Term Debt	Get a 7-Day Free Trial													0.25	-	0.03	-	-

Fusion Antibodies (LSE:FAB) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Fusion Antibodies Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Fusion Antibodies's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Fusion Antibodies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fusion Antibodies PLC (LSE:FAB) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Springbank Road, Springbank Industrial Estate, Dunmurry, Belfast, GBR, BT17 0QL

Website

https://www.fusionantibodies.com

Fusion Antibodies PLC offers various antibody engineering services for all therapeutic and diagnostic antibody development stages. It is engaged in the research, development, and manufacturing of recombinant proteins, particularly in cancer and infectious diseases. Its services include antibody sequencing, antibody humanization, stable cell line development, monoclonal antibody production, and transient protein expression. Geographically company generates the majority of its revenue from North America.

Fusion Antibodies Headlines

From GuruFocus

626 Financial, LLC Buys 3, Sells 2 in 3rd Quarter

By GuruFocus Research GuruFocus Editor • 10-21-2022